ART Fertility Clinics and MOGS to Host ‘Lab to Life’ Conference

art-fertility-clinics-and-mogs-to-host-lab-to-life-conference
Photo credits: Press release

ART Fertility Clinics, a global pioneer in reproductive healthcare, recently collaborated with the Mumbai Obstetric & Gynecological Society (MOGS) to host the Annual Conference 2025 titled ‘Lab to Life’ in Mumbai. This significant event brought together leading international and Indian experts in gynecology, embryology, and Assisted Reproductive Technology (ART) to explore the latest advancements in reproductive medicine.

Uniting Experts Across Disciplines

As per the press release, the conference drew an impressive lineup of participants including fertility specialists, gynecologists, embryologists, researchers, clinicians, lab technologists, and academic scholars. Esteemed global experts such as Prof. Dr. Human Fatemi, Prof. Dr. Barbara Lawrenz, Prof. Dr. Mustafa Baris Ata, Dr. Laura Melado Vidales, and Dr. Ameet Patki shared the stage with leading Indian professionals like Dr. Sujata Dalvi, Dr. Meenakshi Dua, Dr. Akash Surana, and Dr. Rajvi Mehta. Their collective insights created a platform for meaningful discussions and knowledge sharing.

Diving Deep Into Fertility Science

Throughout the day, the conference hosted a series of interactive sessions that highlighted critical topics in reproductive medicine. Discussions included advanced ovarian stimulation protocols, the role of stem cell therapy, and the impact of paternal aging on ART outcomes. Real-life case studies and clinical insights added depth to the panel interactions, enabling participants to explore efficient and evidence-based treatment approaches.

Also Read |  Gleneagles Hospital Parel Partners with City Fire Department for “Brain on Fire” Campaign, Linking Stroke and Fire Emergencies

Addressing Uterine Health and Misconceptions

A key session focused on the uterine environment, where specialists tackled common challenges such as thin endometrium and adenomyosis. The panel emphasized evidence-backed treatments and took the opportunity to debunk persistent myths in reproductive care. Their shared goal: to foster more accurate understanding and trust among both clinicians and patients.

Exploring Future Trends: AI and In Vitro Maturation

As the conclave progressed, the spotlight shifted to the future of fertility care. Experts discussed the evolving role of ART laboratories and the transformative potential of AI in embryology. The session on in vitro maturation (IVM) sparked particular interest, revealing how technology continues to reshape reproductive science.

ART Fertility Clinics: Blending Technology, Expertise, and Compassion

With a legacy rooted in research and personalized care, ART Fertility Clinics has built a reputation for excellence in reproductive medicine. Its clinics across India are powered by advanced embryology labs and a team of ESHRE-certified subspecialists, achieving high success rates and an elevated Live Birth Rate (LB rt%) across diverse patient profiles.

Also Read |  Robotic Knee Surgery Transforms Orthopedic Care in Mumbai

Leadership Speaks: Vision and Values in Fertility Care

Prof. Dr. Human Fatemi is the Group Medical Director of ART Fertility Clinics. He remarked, “At ART Fertility Clinics, every effort centers around helping patients achieve their dream of parenthood. Globally, 15–20% of couples face fertility challenges. To support both male and female infertility, we rely on scientific evidence and a compassionate approach. Our collaboration with MOGS exemplifies how science and empathy can drive transformative care.”

Dr. Somesh Mittal, Chief Executive Officer of ART Fertility Clinics India, added, “Our eleven world-class clinics across India deliver personalized, diagnostics-led fertility care. By identifying root causes and using research-backed treatments, we ensure safe and effective outcomes, consistently driving higher pregnancy success.”

India’s Journey with ART Fertility Clinics

Reflecting on their rapid growth in India, Dr. Parul Katiyar, Medical Director, shared her thoughts. “Since our inception in 2021, we’ve learned immensely,” she said. “We’ve also helped thousands on their fertility journey. Often, we’ve succeeded in enabling patients to conceive with their own gametes, even when other clinics recommended donor cycles. That’s the power of personalized and evidence-based care.”

Also Read |  AIG Hospitals to Introduce South-East Asia’s First DynamicARC Proton Therapy System

Dr. Richa Jagtap, also Medical Director, concluded, “We blend science with the wisdom of nature. Our team of skilled clinicians, embryologists, and nurses works in harmony. Through continuous learning, they deliver exceptional results in fertility treatment.”